March 10, 2020 07:08 AM EDTUpdated 07:41 AM
Coronavirus

Gates Foun­da­tion, Mas­ter­card, Well­come launch coro­n­avirus treat­ment ac­cel­er­a­tor as out­break deep­ens

Jason Mast

Editor

A month af­ter an­nounc­ing it was pre­pared to spend $100 mil­lion on R&D ef­forts against the nov­el coro­n­avirus — and with the out­break show­ing no …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times